Biotech firm NRx Pharmaceuticals plans to change its name and CUSIP number to NRx Therapeutics to combat naked short selling.
Biotech firm NRx Pharmaceuticals plans to change its name and CUSIP number to NRx Therapeutics to combat naked short selling, and intends to require an exchange of stock certificates. This move, which may impact those with "naked short" positions, is supported by former SEC attorneys and brokerage compliance heads. The company also considers a reverse stock split to meet Nasdaq listing requirements.
March 12, 2024
4 Articles